Endoluminal palliation for dysphagia secondary to esophageal carcinoma

Surgical Clinics of North America

Volumn 82, Issue 4, 2002, Pages 747-761

  Weigel, Tracey L ^a   Frumiento, Carmine ^a   Gaumintz, Eric ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEAM THERAPY; BRACHYTHERAPY; CANCER PALLIATIVE THERAPY; DYSPHAGIA; ESOPHAGUS CARCINOMA; HUMAN; LASER SURGERY; NEODYMIUM LASER; PATIENT SELECTION; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; REVIEW; STENT;

BRACHYTHERAPY; DEGLUTITION DISORDERS; ESOPHAGEAL NEOPLASMS; HUMANS; LASER SURGERY; PALLIATIVE CARE; PHOTOCHEMOTHERAPY; STENTS;

EID: 0036703822     PISSN: 00396109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6109(02)00037-3     Document Type: Review

References (45)

1. Brierley JD, Oza AM. Radiation and chemotherapy in the management of malignant esophageal strictures. Gastrointest Endosc Clin N Am 1998;8:451-63.
2. Earlam R, Cunha-Melo JR. Oesophageal squamous cell carcinoma: I. A critical review of surgery [review 163 refs]. Br J Surg 1980;67:381-90.
3. Newaishy GA, Read GA, Duncan W, Kerr GR. Results of radical radiotherapy of squamous cell carcinoma of the oesophagus. Clin Radiol 1982;33:347-52.
4. Okawa T, Kita M, Tanaka M, Ikeda M. Results of radiotherapy for inoperable locally advanced esophageal cancer. Int J Radiat Oncol Biol Phys 1989;17:49-54.
5. Herskovic A, Martz K, al Sarraf M, Leichman L, Brindle J, Vaitkevicius V, et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus [see comments]. N Engl J Med 1992;326:1593-8.
6. Cwikiel M, Cwikiel W, Albertsson M. Palliation of dysphagia in patients with malignant esophageal strictures. Comparison of results of radiotherapy, chemotherapy and esophageal stent treatment. Acta Oncol 1996;35:75-9.
7. Sule-Suso J, Brunt AM, Lindup R, Scoble JE. Hyperfractionated accelerated radiotherapy for carcinoma of the oesophagus. Clin Oncol 1991;3:209-13.
8. Coia LR, Engstrom PF, Paul AR, Stafford PM, Hanks GE. Long-term results of infusional 5-FU, mitomycin-C and radiation as primary management of esophageal carcinoma. Int J Radiat Oncol Biol Phys 1991;20:29-36.
9. Rovirosa A, Marsiglia H, Lartigau E, Zimmermann P, Chirat E, Delapierre M, et al. Endoluminal high-dose-rate brachytherapy with a palliative aim in esophageal cancer: Preliminary results at the Institut Gustave Roussy [review 37 refs]. Tumori 1995;81: 359-63.
10. Sur RK, Donde B, Levin VC, Mannell A. Fractionated high dose rate intraluminal brachytherapy in palliation of advanced esophageal cancer. Int J Radiat Oncol Biol Phys 1998;40:447-53.
11. Davids PH, Groen AK, Rauws EA, Tytgat GN, Huibregtse K. Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction [see comments]. Lancet 1992;340:1488-92.
12. Stemerman DH, Caroline DF, Dabezies M, Mercader VP, Krevsky B, Gatenby RA. Nonexpandable silicone esophageal stents for treatment of malignant tracheoesophageal fistulas: Complications and radiographic appearances. Abdom Imaging 1997;22:14-9.
13. Knyrim K, Wagner HJ, Bethge N, Keymling M, Vakil N. A controlled trial of an expansile metal stent for palliation of esophageal obstruction due to inoperable cancer [see comments]. N Engl J Med 1993;329:1302-7.
14. Ell C, Hochberger J, May A, Fleig WE, Hahn EG. Coated and uncoated self-expanding metal stents for malignant stenosis in the upper GI tract: Preliminary clinical experiences with Wall stents. Am J Gastroenterol 1994;89:1496-500.
15. Grund KE, Storek D, Becker HD. Highly flexible self-expanding meshed metal stents for palliation of malignant esophagogastric obstruction. Endoscopy 1995;27:486-94.
16. Nicholson DA, Haycox A, Kay CL, Rate A, Attwood S, Bancewicz J. The cost effectiveness of metal oesophageal stenting in malignant disease compared with conventional therapy. Clin Radiol 1999;54:212-5.
17. Adam A, Ellul J, Watkinson AF, Tan BS, Morgan RA, Saunders MP, et al. Palliation of inoperable esophageal carcinoma: A prospective randomized trial of laser therapy and stent placement. Radiology 1997;202:344-8.
18. Ramirez FC, Dennert B, Zierer ST, Sanowski RA, Esophageal self-expandable metallic stents - indications, practice, techniques, and complications: Results of a national survey [see comments]. Gastrointest Endosc 1997;45:360-4.
19. Cwikiel W, Willen R, Stridbeck H, Lillo-Gil R, von Holstein CS. Self-expanding stent in the treatment of benign esophageal strictures: Experimental study in pigs and presentation of clinical cases. Radiology 1993;187:667-71.
20. Vakil N, Morris AI, Marcon N, Segalin A, Peracchia A, Bethge N, et al. A prospective, randomized, controlled trial of covered expandable metal stents in the palliation of malignant esophageal obstruction at the gastroesophageal junction. Am J Gastroenterol 2001;96:1791-6.
21. Kinsman KJ, DeGregorio BT, Katon RM, Morrison K, Saxon RR, Keller FS, et al. Prior radiation and chemotherapy increase the risk of life-threatening complications after insertion of metallic stents for esophagogastric malignancy [see comments]. Gastrointest Endosc 1996;43:196-203.
22. Siersema PD, Hop WC, Dees J, Tilanus HW, van Blankenstein M. Coated self-expanding metal stents versus latex prostheses for esophagogastric cancer with special reference to prior radiation and chemotherapy: A controlled, prospective study [see comments], Gastrointest Endosc 1998;47:113-20.
23. McIntee BE. The wall stent endoprosthesis [review 6 refs]. Gastrointest Endosc Clin N Am 1999;9:373-81.
24. Schmassmann A, Meyenberger C, Knuchel J, Binek J, Lammer F, Kleiner B, et al. Self-expanding metal stents in malignant esophageal obstruction: A comparison between two stent types [see comments]. Am J Gastroenterol 1997;92:400-6.
25. De Palma GD, di Matteo E, Romano G, Fimmano A, Rondinone G, Catanzano C. Plastic prosthesis versus expandable metal stents for palliation of inoperable esophageal thoracic carcinoma: A controlled prospective study. Gastrointest Endosc 1996;43:478-82.
26. Ludwig D, Dehne A, Burmester E, Wiedemann GJ, Stange EF. Treatment of unresectable carcinoma of the esophagus or the gastroesophageal junction by mesh stents with or without radiochemotherapy. Int J Oncol 1998;13:583-8.
27. Bethge N, Sommer A, von Kleist D, Vakil N. A prospective trial of self-expanding metal stents in the palliation of malignant esophageal obstruction after failure of primary curative therapy. Gastrointest Endosc 1996;44:283-6.
28. Gossner L, Ell C. Malignant strictures. Thermal treatment [review 42 refs]. Gastrointest Endosc Clin N Am 1998;8:493-501.
29. Krasner N. Palliative laser therapy for turnouts of the gastrointestinal tract [review 109 refs]. Baillieres Clin Gastroenterol 1991;5:37-59.
30. Mitty RD, Cave DR, Birkett DH. One-stage retrograde approach to Nd:YAG laser palliation of esophageal carcinoma. Endoscopy 1996;28:350-5.
31. Cotton BP, Williams CP. Practical Gastrointestinal Endoscopy. 4th Edition. London: Blackwell Science; 1996.
32. Low DE, Pagliero KM. Prospective randomized clinical trial comparing brachytherapy and laser photoablation for palliation of esophageal cancer. J Thorac Cardiovasc Surg 1992;104:173-8.
33. Carter R, Smith JS, Anderson JR. Laser recanalization versus endoscopic intubation in the palliation of malignant dysphagia: A randomized prospective study. Br J Surg 1992; 79:1167-70.
34. Ell C, May A. Self-expanding metal stents for palliation of stenosing tumors of the esophagus and cardia: A critical review [review 40 refs]. Endoscopy 1997;29:392-8.
35. Gevers AM, Macken E, Hiele M, Rutgeerts P. A comparison of laser therapy, plastic stents, and expandable metal stents for palliation of malignant dysphagia in patients without a fistula. Gastrointest Endosc 1998;48:383-8.
36. Bown SG. Palliation of malignant dysphagia: Surgery, radiotherapy, laser, intubation alone or in combination? Gut 1991;32:841-4.
37. Sander R, Hagenmueller F, Sander C, Riess G, Classen M. Laser versus laser plus afterloading with iridium-192 in the palliative treatment of malignant stenosis of the esophagus: A prospective, randomized, and controlled study. Gastrointest Endosc 1991; 37:433-40.
38. Spencer GM, Thorpe SM, Sargeant IR, Blackman GM, Solano J, Tobias JS, et al. Laser and brachytherapy in the palliation of adenocarcinoma of the oesophagus and cardia. Gut 1996;39:726-31.
39. Forbes IJ, Cowled PA, Leong AS, Ward AD, Black RB, Blake AJ, et al. Phototherapy of human tumours using haematoporphyrin derivative. Med J Aust 1980;2:489-93.
40. Saidi RF, Marcon NE. Nonthermal ablation of malignant esophageal strictures. Photodynamic therapy, endoscopic intratumoral injections, and novel modalities [review 102 refs]. Gastrointest Endosc Clin N Am 1998;8:465-91.
41. Barr H, Bown SG. Normal tissue damage following photodynamic therapy: Are there biological advantages? Henderson B, Dougherty TJ, editors. Photodynamic Therapy - Basic Principles and Clinical Applications. New York: Dekker; 1992. p. 201.
42. Barr H, Chatlani P, Tralau CJ, MacRobert AJ, Boulos PB, Bown SG. Local eradication of rat colon cancer with photodynamic therapy: Correlation of distribution of photosensitiser with biological effects in normal and tumour tissue. Gut 1991;32:517-23.
43. Thomas RJ, Abbott M, Bhathal PS, St John DJ, Morstyn G. High-dose photoirradiation of esophageal cancer. Ann Surg 1987;206:193-9.
44. Schweitzer VG, Bologna S, Batra SK. Photodynamic therapy for treatment of esophageal cancer: A preliminary report. Laryngoscope 1993;103:699-703.
45. Lightdale CJ, Heier SK, Marcon NE, McCaughan JS Jr, Gerdes H, Overholt BF, et al. Photodynamic therapy with porfimer sodium versus thermal ablation therapy with Nd:YAG laser for palliation of esophageal cancer: A multicenter randomized trial. Gastrointest Endosc 1995;42:507-12.